Initiative to reduce bone scans for low-risk prostate cancer patients: A quasi-experimental before-and-after study in a Veterans Affairs hospital

by Eric Ojerholm, MD, Keith N. Van Arsdalen, MD, FACS, Robert E. Roses, MD, Patrick Tripp, MD
Published 2017-07-01

Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy

by Jashodeep eDatta, Erik eBerk, Jessica A Cintolo, Shuwen eXu, Robert E Roses, Brian J Czerniecki
Published 2015-06-01

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

by Brett L Ecker, Laura Taylor, Paul J Zhang, Emma E Furth, Gregory G Ginsberg, Matthew T McMillan, Jashodeep Datta, Brian J Czerniecki, Robert E Roses
Published 2016-01-01

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2p...

by Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, Megan Fracol, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Robert E. Roses, Carla S. Fisher, Elizabeth S. McDonald, Paul J. Zhang, Angela DeMichele, Rosemarie Mick, Gary K. Koski, Brian J. Czerniecki
Published 2017-09-01